Updated results at 6 year of the GERCOR C96.1 phase III study comparing LV5FU2 to monthly 5FU-leucovorin (mFufol) as adjuvant treatment for Dukes B2 and C colon cancer patients
暂无分享,去创建一个
M. Buyse | O. Bouché | E. Gamelin | P. Piedbois | A. Gramont | T. André | C. Louvet | E. Quinaux | N. Tubiana-Mathieu | E. Achille